Virpax shares rise on expanded licensing deal for experimental drug
March 15, 2022 at 10:06 AM EDT
The new drug candidate showed effectives against influenza and SARS-CoV-2 in preclinical studies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|